Skip to content
Review

TWIST family in cervical cancer biology: From molecular mechanisms to clinical implications.

Nov 2026 · Experimental Cell Research · pp. 115215 · 0 citations · 174 references
Medicine

Abstract

Despite ongoing clinical efforts, cervical cancer remains one of the most common gynecologic tumors, largely due to its metastatic potential and resistance to chemotherapy. The transcriptional regulator TWIST has been implicated in these features, in part through the induction of epithelial-mesenchymal transition (EMT). The expression of TWIST is delicately regulated by several exogenous factors, including hypoxia-driven HIF-1α signaling and TGF-β pathways, as well as endogenous oncogenic cascades such as Wnt/β-catenin, NF-κB, PI3K/Akt, Hedgehog, Notch, and IL-6/JAK2/STAT3. Moreover, the E6 and E7 proteins from high-risk human papillomavirus strains promote TWIST upregulation, facilitating cellular plasticity and evasion of senescence. Post-transcriptional and epigenetic regulation is orchestrated by complex networks of non-coding RNAs and key transcription factors such as Mist1, FOXC1, and LMX-1A. Importantly, hypermethylation of the TWIST1 promoter has been proposed as a candidate biomarker for cervical intraepithelial neoplasia. TWIST has been reported to promote tumor-associated phenotypes through E-cadherin downregulation, induction of matrix metalloproteinases, and maintenance of stem cell-like properties. TWIST has been associated with chemotherapy and radiotherapy resistance, potentially through mechanisms involving DNA-damage responses and MDR1/P-glycoprotein-mediated drug efflux. The tumor microenvironment affects its expression and activity, including hypoxia, cancer-associated fibroblasts, inflammatory cytokines, tumor-associated macrophages, and extracellular vesicles. In a clinical context, high levels of TWIST are linked to poor outcomes in cervical cancer. Growing evidence links it to immune evasion through regulation of PD-L1, immunosuppressive cytokine signaling, macrophage polarization, T-cell exclusion, and immune resistance associated with cancer stem cells, underscoring its importance for translation in the current era of immune checkpoint blockade.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.